Loading, Please Wait...
SANTA CLARA, Calif., Sept. 11, 2019 (GLOBE NEWSWIRE) -- Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Curation Foods, Inc. and Lifecore Biomedical, Inc., will hold a conference call on Wednesday October 2, 2019 at 8 a.m. Pacific time to discuss its results for the first quarter fiscal year 2020. Financial results will be reported for the 2020 fiscal first quarter ended August 25, 2019 after market close on October 1, 2019.
Landec's President and CEO, Dr. Albert D. Bolles, will host the Conference Call with Gregory S. Skinner, Executive Vice President Finance and CFO. A question and answer period will follow the presentation.
Date: Wednesday October 2, 2019
Time: 8 a.m. Pacific time (11 a.m. Eastern time)
Toll Free Participant Dial-in Number: 1-877-407-3982
U.S. and International Toll Number: 1-201-493-6780
Conference ID: 13694436
The webcast will be available for 30 days through November 1, 2019.
A replay of the teleconference will be available for one week until midnight Eastern Time on Wednesday October 9, 2019.
Toll free replay dial in: 1-844-512-2921
International replay: 1-412-317-6671
Replay passcode: 13694436
About Landec Corporation
Landec Corporation (Nasdaq: LNDC) is a leading innovator of diversified health and wellness solutions with two operating businesses: Curation Foods, Inc. and Lifecore Biomedical, Inc. Curation Foods is focused on innovating and distributing plant-based foods with 100% clean ingredients to retail, club and foodservice channels throughout North America. Curation Foods is able to maximize product freshness through its geographically dispersed family of growers, refrigerated supply chain and patented BreatheWay® packaging technology. Curation Foods brands include Eat Smart® fresh packaged vegetables and salads, O Olive Oil & Vinegar® premium artisan products, and Yucatan® and Cabo Fresh® avocado products. Lifecore Biomedical is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of difficult to manufacture pharmaceutical products in syringes and vials. As a leading manufacturer of premium, injectable grade Hyaluronic Acid, Lifecore brings 35 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Landec’s website at www.landec.com.
|At the Company:||Investor Relations:|
|Gregory S. Skinner||Jeff Sonnek|
|Executive Vice President Finance and CFO||(646) 277-1263|